AXON stock forecast, quote, news & analysis
Axon Enterprise Inc is building a public safety operating system by integrating a suite of hardware devices and cloud software solutions... Show more
Why Axon Enterprise (AXON) Stock Is Down -12.3% in the Last 30 Days
Key Takeaways
- Axon Enterprise (AXON) shares fell about 12.3% over the last 30 days, from a closing price near $447.76 to approximately $392.69.
- The decline has been driven mainly by a broad de-rating of high-multiple software and SaaS stocks, not by weaker underlying business results.
- A $1.0 billion convertible senior notes offering, plus an option for up to $150 million more, added dilution overhang during the period.
- Piper Sandler lowered its price target to $561 from $732 on October 20, 2026, while keeping an Overweight rating.
- The stock now trades roughly 49% below its 52-week high of $764.02, with next earnings expected in early November 2026.
Axon Enterprise (AXON) Company Overview and Market Position
Axon Enterprise is a global public safety technology company best known for its TASER conducted energy devices, but its growth increasingly comes from a connected ecosystem of hardware and software. The company develops and sells body-worn cameras, in-car and fleet cameras, drone and counter-drone technology (through its Dedrone business), and a suite of cloud-based software that includes Evidence.com, Axon Records, and AI-assisted tools such as Draft One. It serves law enforcement, federal agencies, corrections, fire and emergency services, enterprises, and consumers. With a large recurring revenue base and a future contracted bookings backlog exceeding $15 billion, Axon is positioned as a leader in the digital transformation of public safety.
Axon Enterprise (AXON) Stock Price Performance: Last 30 Days vs. Quarter
Over the last 30 days, AXON declined roughly 12.3%, sliding from a closing price near $447.76 on September 18, 2026 to about $392.69. The move was not a straight line: the stock posted its sharpest single-session drop of the period on October 16, falling 6.4%, before stabilizing near the $390 level.
The broader three-month trend has been substantially weaker. From the roughly $575–$645 range seen in early-to-mid August 2026, including a peak close near $645.72 on August 19, shares have fallen more than 30% to current levels. This extended drawdown reflects a sustained repricing of the stock's valuation multiple rather than any single quarterly disappointment.
What Drove AXON Stock Price in the Last 30 Days
The most significant driver has been a valuation reset across high-multiple software and SaaS companies. As investors rotated away from richly valued growth names, Axon's forward earnings multiple—which had reached well above 130 times at its peak—compressed sharply even as the company continued to report strong operating results.
Corporate financing activity also weighed on sentiment. In mid-September, Axon priced a $1.0 billion offering of 0% convertible senior notes due 2031, with underwriters granted an option for an additional $150 million; the full $1.15 billion raise was subsequently completed. Convertible offerings can create perceived dilution overhang and contributed to selling pressure. Separately, Piper Sandler lowered its price target to $561 from $732 on October 20, 2026, while maintaining an Overweight rating, and regulatory scrutiny of AI-driven surveillance technologies added a layer of uncertainty around the broader sector.
What Drove AXON Stock Performance Over the Last Quarter
The quarterly decline began with the company's second-quarter earnings report in early August 2026. Axon beat expectations on both revenue and earnings, delivering revenue of about $904.3 million (up 35% year over year) and raising full-year revenue growth guidance to a range of 32%–34%. Despite the beat, shares fell more than 6% after-hours as investors focused on anticipated third-quarter margin pressure from rising memory component costs and the absence of a one-time tariff refund benefit.
Since then, the stock has been caught in the broader selloff in growth-oriented software names. Fundamentals have remained resilient—future contracted bookings grew more than 40% year over year—but the market has steadily assigned a lower multiple to that growth. The result is a stock that is down substantially from its peak despite an intact operating story, a classic case of multiple compression outweighing business momentum.
Trending AI Robots
For investors seeking a data-driven approach to market moves like this one, Tickeron's Trending AI Robots page offers a curated view of its algorithmic trading tools. Tickeron provides hundreds of AI trading bots that trade thousands of tickers, but only the top-performing and most relevant bots are featured in this section. These bots vary widely in strategy, timeframe, and performance metrics, allowing users to compare approaches and find signals that match their own objectives and risk tolerance. Exploring the page can help traders identify momentum, reversal, and trend patterns across a broad range of securities.
AXON Stock Forecast Drivers: What Investors Should Watch Next
Looking ahead, the primary catalyst is Axon's third-quarter earnings report, expected in early November 2026. Investors will focus on whether revenue growth holds above 30%, how margin pressure from memory costs evolves, and whether guidance for the seasonally strong fourth quarter is reaffirmed. Demand signals in body-worn cameras, AI-powered software such as Draft One, and the counter-drone business will also matter.
Beyond earnings, watch developments in regulatory and privacy oversight of AI surveillance and license-plate-reader technology, which could influence sentiment across the sector. Finally, valuation remains a central debate: whether the market continues to de-rate high-multiple software names or begins to reward durable growth again will likely shape AXON's near-term path. None of this constitutes a prediction of future performance, and investors should weigh these factors alongside their own research and risk tolerance.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
AXON's RSI Indicator climbs out of oversold territory
The RSI Oscillator for AXON moved out of oversold territory on October 20, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 27 similar instances when the indicator left oversold territory. In 23 of the 27 cases the stock moved higher. This puts the odds of a move higher at 85%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for AXON just turned positive on October 06, 2026. Looking at past instances where AXON's MACD turned positive, the stock continued to rise in 28 of 39 cases over the following month. The odds of a continued upward trend are 72%.
Following a +4.41% 3-day Advance, the price is estimated to grow further. Considering data from situations where AXON advanced for three days, in 273 of 370 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
AXON may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXON declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
The Aroon Indicator for AXON entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 44 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. AXON’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 69 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AXON’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.294) is normal, around the industry mean (4.788). AXON has a moderately high P/E Ratio (170.190) as compared to the industry average of (16.638). Projected Growth (PEG Ratio) (1.949) is also within normal values, averaging (2.564). Dividend Yield (0.000) settles around the average of (0.060) among similar stocks. P/S Ratio (12.034) is also within normal values, averaging (18.330).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a clinical-stage biopharmaceutical company
Industry AerospaceDefense